Study of XmAb412 in Healthy Participants | MicrobiomeTrials← Back to trialsNCT07713485
Study of XmAb412 in Healthy Participants
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07-13Est. Completion: 2027-05
Enrollment target: 128 participants Locations- Xencor Investigative Site, Joondalup, Western Australia, Australia
- Xencor Investigative Site, Nedlands, Western Australia, Australia
Other microbiome trials you might be interested in
Insulin Dependent DiabetesDiabetes (DM)Diabetes (Insulin-requiring, Type 1 or Type 2)Diabetes EducationDiabetes CareType 1 Diabetes (T1D)Type 2 Diabetes Mellitus (T2DM)
This study is designed to test the preliminary efficacy of a three-stage continuous glucose monitor (CGM) integration pr…
Chapel Hill, United StatesEst. completion Jan 2028
Physical ActivityDiet QualitySleepCardiometabolic Health
Digital Intervention
The overarching aim is to improve cardiometabolic health and promote healthy ageing by supporting adults to adopt favour…
Singapore, SingaporeEst. completion Jun 30, 2031
Core Binding Factor Alpha SubunitsHematologic NeoplasmsLeukemiaLymphoma
Background:
Some blood cancers can be caused by germline variants (changes) in a person s RUNX1 gene. Germline variants…
Bethesda, United StatesEst. completion Jun 1, 2033